Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Q301--FoundationOne Malignancy Testing Intent Notice…

U.S. Department Of Veterans Affairs·Ohio

Q301--FoundationOne Malignancy Testing Intent Notice Indianapolis, IN

Closes 8/24/2026$12M – $24MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs (VA) Network 10 Contracting Office intends to award a sole‑source, base‑year plus four one‑year option contract to Foundation Medicine, Inc. for proprietary molecular pathology testing (FoundationOne CDx with RNA, Liquid CDx, Hematology and IHC) to support the Pathology and Laboratory Service at the Richard L. Roudebush VA Medical Center in Indianapolis, IN. The VA will evaluate any written response that demonstrates competitive pricing; otherwise, the contract will be awarded without competition. The solicitation requires electronic submission of a price proposal by the response deadline. • Sole‑source award to Foundation Medicine for specialized cancer diagnostic testing. • Base year with four optional one‑year extensions (up to 5 years total). • Services performed for VA pathology lab in Indianapolis, IN. • NAICS 621511 (Medical Laboratories) with a $41.5 M size standard. • Responses due August 24 2026, 11:00 AM EDT via email to the Contract Specialist. • No telephone inquiries accepted; only written submissions considered.

Attached files

Contact

Jessica Bryant(Contract Specialist)

[email protected]

Key dates

Opened
8/20/2026
Closes
8/24/2026
Duration
5 years

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
36C25026Q0891

Budget estimate

$12,000,000 – $24,000,000

The VA typically funds large‑scale molecular diagnostic contracts at several million dollars per year. Assuming an average per‑test reimbursement of $1,200 and an estimated 2,000–4,000 tests annually for a regional VA medical center, the annual contract value could range from roughly $2.4 M to $4.8 M. Including overhead, support, and optional years, the total five‑year contract value might be between $12 M and $24 M. Factors influencing the final amount include the volume of tests ordered, negotiated pricing, and any additional service fees for data integration or reporting.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Defense·Maryland

Top match · 67%

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

Michigan Department of Health and Human Services Procurement Office·Michigan

67% match

Notice of intent to award ITN 270000000002

Closes 11/2/2026Opened 10/29/2026

NYS Nassau Health Care Corporation·New York

67% match

Notice of Intent to Award - Sole Source: Item# XPRS4PLEX-10

Closes 11/4/2026Opened 10/14/2026

U.S. National Institutes of Health·United States of America

67% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

Indiana Dept of Administration·Indiana

67% match

RFP 27-88872 Toxicology Services

Closes 11/30/2026Opened 10/15/2026

U.S. Department Of Health And Human Services·Maryland

67% match

NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”

Closes 11/20/2026Opened 10/20/2026

U.S. National Institutes of Health·United States of America

66% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

U.S. National Institutes of Health·United States of America

66% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

Department of Environmental Services·South Carolina

66% match

Notice Of Intent To Sole Source

Rolling / TBD closeOpened 10/22/2026

U.S. National Institutes of Health·United States of America

66% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

66% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

66% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

65% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. Department Of Veterans Affairs·Illinois

65% match

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Closes 11/3/2026Opened 10/27/2026

Department of Public Health·South Carolina

65% match

Notice Of Intent To Sole Source By: Department of Public Health

Rolling / TBD closeOpened 10/1/2026

U.S. National Institutes of Health·United States of America

65% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

65% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

65% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

65% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

65% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

65% match

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

Closes 5/7/2029Opened 9/15/2025

Maryland Department of Health·Maryland

65% match

PHPA 4166: Maryland Volunteer and Professional Firefighters Innovative Cancer Screening Technologies Program

Closes 11/20/2026Opened 9/21/2026

U.S. Department Of Health And Human Services·New Mexico

65% match

Notice of Intent to Sole Source - NNMC Laboratory Proficiency Testing Services

Closes 11/16/2026Opened 10/30/2026

U.S. Department Of Veterans Affairs·New Jersey

65% match

Q301--Reference and Esoteric Laboratory Testing

Closes 11/30/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

65% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026